Related Experiment Video

Updated: Jun 22, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

Novel drug delivery strategies in neuro-oncology

Dani S Bidros1, Michael A Vogelbaum

  • 1Department of Neurological Surgery, Brain Tumor and NeuroOncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|June 30, 2009
PubMed

Insights

Treating malignant gliomas is challenging due to the blood-brain barrier. This review explores methods like blood-brain barrier disruption and convection-enhanced delivery to improve drug delivery for brain tumors.

Area of Science:

  • Neuro-oncology
  • Drug Delivery Systems
  • Cancer Therapeutics

Background:

  • Malignant gliomas, including glioblastoma, have poor prognoses despite standard treatments.
  • The blood-brain barrier (BBB) significantly impedes the delivery of therapeutic agents to brain tumors.
  • Effective drug delivery to brain tumor cells remains a critical challenge in neuro-oncology.

Purpose of the Study:

  • To review clinically available methods for circumventing the blood-brain barrier (BBB).
  • To summarize the outcomes of clinical trials investigating novel drug delivery techniques for malignant brain tumors.
  • To provide an overview of strategies aimed at enhancing therapeutic efficacy for brain cancers.

Main Methods:

  • Description of established methods to bypass the blood-brain barrier.
  • Summary of results from completed and ongoing clinical trials.
  • Analysis of investigational delivery techniques such as BBB disruption and convection-enhanced delivery.

Main Results:

  • Clinical trials using BBB disruption and convection-enhanced delivery have yielded mixed results.
  • Ongoing trials are exploring further applications and refinements of these delivery methods.
  • The efficacy of these techniques in improving patient outcomes is under continued investigation.

Conclusions:

  • Circumventing the blood-brain barrier is crucial for effective malignant glioma treatment.
  • Blood-brain barrier disruption and convection-enhanced delivery show promise but require further validation.
  • Continued research and clinical trials are essential to optimize drug delivery strategies for brain tumors.

More Related Videos

Facilitating Repeat Intracarotid Injections in Mouse Models by a Novel Injection Site Repair Technique09:08

Facilitating Repeat Intracarotid Injections in Mouse Models by a Novel Injection Site Repair Technique

Published on: March 15, 2024

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery06:41

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Published on: January 31, 2017

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...